BJERKHOLT ERIC (CHIEF FINANCIAL OFFICER) sold 2.4% of their position (1.05K shares) of MIRUM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $101.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/27/2026ACC: 0001197350-26-000002
Officer· CHIEF FINANCIAL OFFICER
Since Jan 2026
-1.05K
Net shares
Net seller
$101.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.67K acquired · 3.72K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.67K
Price / share
—
Trade value
—
% of position
6.3%
1/23/2026
42.13K→44.79K
Common Stock
Direct
Shares
−1.05K
Price / share
$96.19
Trade value
$101.29K
% of position
2.4%
1/26/2026
44.79K→43.74K
Total
Net shares
+1.61K
Net value
-$101.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2026 | M · Option Exercise | +2.67K | — | — | 6.3% | 42.13K | 44.79K |
| Common Stock Direct | 1/26/2026 | S · Sale | −1.05K | $96.19 | $101.29K | 2.4% | 44.79K | 43.74K |
| Total | +1.61K | -$101.29K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
2.67K shares
Shares
−2.67K
Strike price
Held after
2.67K
Exercisable
—
1/23/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock2.67K shares | 1/23/2026 | M · Option Exercise | −2.67K | — | 2.67K |